Vir Biotechnology Inc (VIR) support and resistance · rev $74.2M
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
This page maps Vir Biotechnology Inc (VIR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
VIR currently screens at market cap $1.45B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VIR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VIR quote page for the session range and the stock page for the full model.
Not investment advice.